Anal squamous cell carcinoma (ASCC) is a rare neoplasm. Chemoradiotherapy is the
standard of care, with no therapeutic advances achieved over the past three decades. Thus, a …

Triple-negative breast cancer is a heterogeneous disease characterized by a lack of hormonal
receptors and HER2 overexpression. It is the only breast cancer subgroup that does not …

Breast cancer is a heterogeneous disease comprising a variety of entities with various
genetic backgrounds. Estrogen receptor-positive, human epidermal growth factor receptor 2-…

Background Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancers
and usually requires the administration of adjuvant chemotherapy after surgery but even …

Background Muscle-invasive bladder tumors are associated with a high risk of relapse and
metastasis even after neoadjuvant chemotherapy and radical cystectomy. Therefore, further …

Metabolic reprogramming is a hallmark of cancer. It has been described that breast cancer
subtypes present metabolism differences and this fact enables the possibility of using …

Background Metabolomics has a great potential in the development of new biomarkers in
cancer and it has experiment recent technical advances. Methods In this study, metabolomics …

Traditionally, bladder cancer has been classified based on histology features. Recently, some
works have proposed a molecular classification of invasive bladder tumors. To determine …

Simple Summary Colorectal cancer is a heterogeneous disease. Several efforts have been
made to characterize this heterogeneity but they have no impact in the clinic. In this work, we …

Melanoma is the most lethal cutaneous cancer. New drugs have recently appeared; however,
not all patients obtain a benefit of these new drugs. For this reason, it is still necessary to …